FDA Approves Additional Option for Measles, Mumps and Rubella Vaccination

The FDA has approved the Priorix vaccine for the prevention of measles, mumps and rubella in individuals 12 months of age and older.

Related Keywords

,Centers For Disease ,Glaxosmithkline ,Drug Administration ,Prevention Advisory Committee On Immunization Practices ,Us Medical Affairs ,Temi Folaranmi ,Vice President ,Vaccines Therapeutic Area Head ,Disease Control ,Advisory Committee ,Immunization Practices ,